Craig D. Cairns - May 21, 2021 Form 4 Insider Report for TRANSCAT INC (TRNS)

Role: Director
Signature: /s/ James M. Jenkins, Attorney-in-Fact for Craig D. Cairns
Stock symbol: TRNS
Transactions as of: May 21, 2021
Transactions value $: $101,238
Form type: 4
Date filed: 5/24/2021, 04:20 PM
Previous filing: May 13, 2021
Next filing: Sep 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TRNS	Common Stock, $.50 par value	Purchase	$101K	+1.75K		$57.85	1.75K	May 21, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TRNS	Stock Option (Right to Buy)						10K	May 21, 2021	Common Stock, $.50 par value	10K	$47.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $57.76 to $58.00, inclusive. Mr. Cairns undertakes to provide Transcat, Inc., any security holder of Transcat, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award notice.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $57.76 to $58.00, inclusive. Mr. Cairns undertakes to provide Transcat, Inc., any security holder of Transcat, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award notice.